Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1528088127
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6550 Fannin St, Suite 1101
Houston, TX, 77030
Phone (713) 441-0006
Groups this clinician bills Medicare through
Medicare paid, 2024
$147K
4,936 services
Medicare patients, 2024
321
Average age 67
Drug cost, 2024
$1.8M
4,021 prescriptions
Company payments, 2025
$59.83
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Archana R Sadhu was code J0897 (injection, denosumab, 1 mg), 3,900 times for 41 patients. In total Archana R Sadhu billed 4,936 services in 26 codes, and Medicare paid $147K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,900 | 41 | $20.52 | $80K |
| 99215 Office E&M - Established | Office | 251 | 158 | $125.09 | $31K |
| 95251 Test - Miscellaneous | Office | 123 | 67 | $24.83 | $3,053 |
| 99214 Office E&M - Established | Office | 108 | 86 | $94.31 | $10K |
| 96372 Injection Administration | Office | 66 | 42 | $10.81 | $713 |
| 99222 Hospital E&M - Initial | Facility | 54 | 52 | $100.23 | $5,412 |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 30 | $62.97 | $2,960 |
| 99223 Hospital E&M - Initial | Facility | 46 | 46 | $133.72 | $6,151 |
| 83036 Blood Count | Office | 32 | 30 | $9.52 | $305 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 14 | $32.75 | $524 |
| 90662 Vaccine Product | Office | 16 | 14 | $77.19 | $1,235 |
By year: 2022 $153K for 5,028 services; 2023 $161K for 5,373 services; 2024 $147K for 4,936 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 32 | 30 | $9.52 | $305 |
Medicare prescription drug claims, 2024
In 2024, the drug Archana R Sadhu prescribed most often to Medicare patients was Ozempic (Semaglutide), with 474 prescriptions and refills. In total Archana R Sadhu wrote 4,021 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 474 | 581 | 77 | $528K |
| Levothyroxine Sodium Generic | 298 | 749 | 65 | $3,284 |
| Atorvastatin Calcium Generic | 290 | 675 | 79 | $2,690 |
| Tradjenta Linagliptin | 248 | 531 | 65 | $252K |
| Jardiance Empagliflozin | 235 | 418 | 49 | $238K |
| Metformin Hcl Generic | 159 | 349 | 39 | $742 |
| Mounjaro Tirzepatide | 147 | 162 | 29 | $165K |
| Rosuvastatin Calcium Generic | 129 | 314 | 35 | $2,314 |
| Ezetimibe Generic | 112 | 287 | 30 | $3,904 |
| Gabapentin Generic | 106 | 156 | 21 | $1,067 |
| Januvia Sitagliptin Phosphate | 91 | 145 | 20 | $76K |
| Humalog Kwikpen U-100 Insulin Lispro | 79 | 170 | 36 | $18K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 78 | 151 | 24 | $16K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 73 | 147 | 26 | $11K |
| Novolog Flexpen Insulin Aspart | 72 | 144 | 33 | $22K |
Brand drugs: 2,181 claims; generic drugs: 1,602 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Archana R Sadhu $59.83 ($59.83 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $22.41.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.